Given the arduous path to drug development, there’s nothing like the joy of bringing an important or even life-saving therapy ...

The maker of Panadol, Sensodyne toothpaste and Centrum vitamins posted a higher pretax profit for 2024 despite lower revenue.

The consumer-health giant, which was spun out of GSK and is partly owned by Pfizer ... compared with 1.63 billion pounds a year ago. The maker of Panadol tablets, Sensodyne toothpaste and Centrum ...

Haleon’s (HLN) sales in 2024 were in line with broker estimates, but reported earnings came up short of expectations. That came after an improved showing in a fourth quarter in which it delivered on ...

The blue chip, which was spun out of GSK in 2022 and also owns Voltaren and Panadol, among others, expects organic revenues to grow by between 4% and 6% in the current year, with profit growth ...

In 2022, the company also inked a contract manufacturing deal with Haleon (then GSK Consumer Healthcare), which owns brands including Panadol, Sensodyne, Voltaren, Polident, Centrum, Otrivin and ...

In 2022 Wellnex also inked a contract manufacturing deal with Haleon (then GSK Consumer Healthcare), which owns brands including Panadol, Sensodyne, Voltaren, Polident, Centrum, Otrivin and Advil.

hit by a stronger pound and lower sales of its painkiller Panadol in Australia and the Middle East. GSK shares jump on $2.2 billion Zantac settlement GSK shares jumped as much as 6.5% on Thursday ...

Haleon Sri Lanka formerly known as GlaxoSmithKline Healthcare; the first multinational pharmaceutical manufacturing organization in Sri Lanka, which commenced manufacturing in 1956 with the flagship ...